Status:

WITHDRAWN

Investigating RELEARN Neurofeedback as Treatment for Chronic Musculoskeletal Pain

Lead Sponsor:

Redo-Neurosystems

Collaborating Sponsors:

Regionshospital Nordjylland

Conditions:

Chronic Knee Pain

Chronic Pain

Eligibility:

All Genders

18-65 years

Phase:

PHASE2

PHASE3

Brief Summary

This clinical investigation will be carried out as a randomized controlled trial conducted at the Northern Regional Hospital, Hjørring. This investigation will enrol 36 patients suffering from severe ...

Detailed Description

The participants will be randomized into treatment group A and control group B, 1:1 and be stratified based on age, sex, and ethnicity. Group A participants will be asked to attend eight sessions of R...

Eligibility Criteria

Inclusion

  • Age 18-65 years old
  • Knee arthrosis (Kellgren-Lawrence score of ≥ 2)
  • 24h VAS ≥ 4
  • Ongoing pain, lasting more than three months

Exclusion

  • Participants who meet any of the below criteria will be excluded from the investigation:
  • Pregnant or lactating woman
  • Use of opioids or cannabis
  • Active drug addiction defined as the use of cannabis, opioids, or other drugs
  • Previous or current neurologic, systemic, or mental illness, including any liver, kidney or metabolic disease.
  • Rheumatoid arthritis
  • Evidence of other pain types such as visceral, neuropathic, or malignant pain.
  • Evidence of other sources of ongoing pain such as root affect, traumas, or congenital malformation
  • Severe inflammation in the area of interest
  • Blindness or deafness
  • Consumption of alcohol, caffeine, nicotine on test day
  • Recent history of fractures or surgery in the area of interest
  • Participation in other clinical trials throughout the study period and one month prior to participation
  • History of epilepsy
  • Obesity class III and above. I.e. BMI \> 39,9

Key Trial Info

Start Date :

October 5 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2023

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT05335486

Start Date

October 5 2022

End Date

July 1 2023

Last Update

February 6 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Center for Clinical Research

Hjørring, Denmark, 9800